Sonoma Pharmaceuticals, Inc. — Director's Dealing 2007

Jan 24, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2007-01-24

Reporting Person: Miller Robert E (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Direct
Common Stock	50000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$10.16	2015-10-01	Common Stock (6250)		Direct
Stock option (right to buy)	$3.00	2014-07-10	Common Stock (34633)		Direct
Stock option (right to buy)	$3.00	2014-07-10	Common Stock (39181)		Direct

Footnotes

F1: The option became exercisable as to 20% of the shares on October 1, 2006, and becomes exercisable as to 1/60th of the remaining shares each full month thereafter.

F2: The option became fully exercisable on July 10, 2004. 60,000 shares have been exercised.

F3: The option became fully exercisable on September 30, 2005.